Louisiana Genetic Privacy: Consent Requirements and Limits When Clinics Offer Carrier Screening Panels

Louisiana sets clear guardrails for how clinics handle genetic information when they offer carrier screening panels. This guide distills the state’s consent rules, confidentiality standards, anti-discrimination protections, and insurance and employment limits so you can build compliant, patient-centered workflows.

Genetic Test Confidentiality

Under Louisiana law, prenatal and postnatal genetic test results—including those from carrier screening panels—are confidential medical information. They must be treated as part of the patient’s medical record and may not be disclosed without the patient’s express written consent. ([legis.la.gov](https://www.legis.la.gov/legis/Law.aspx?d=965051&utm_source=openai))

Clinics must also respect medical record confidentiality more generally. While a provider owns the physical record, you must furnish copies upon a patient’s request (with narrow exceptions) and safeguard the information throughout its lifecycle. ([legis.la.gov](https://www.legis.la.gov/legis/Law.aspx?d=964709))

What this means for clinics offering carrier screening panels

• Explain how results will be recorded in the medical record and protected under Medical Record Confidentiality and Genetic Information Confidentiality rules. ([legis.la.gov](https://www.legis.la.gov/legis/Law.aspx?d=965051&utm_source=openai))
• Segregate access to genetic results to “need-to-know” personnel and document all disclosures.
• Prepare a streamlined process for patient requests for copies of their results and for restricting further disclosures.

Authorization for Disclosure

Louisiana draws a bright line between general releases and Genetic Data Authorization. A generic medical-records release does not suffice to disclose genetic information; you need a distinct, Written Informed Consent that meets statutory content requirements. ([legis.la.gov](https://legis.la.gov/legis/LawPrint.aspx?d=507863))

Required elements of a valid genetic authorization (for insurers and any third‑party disclosures)

• Written, signed, and dated authorization by the individual.
• Who may disclose the information.
• Specific description of the genetic information to be disclosed.
• To whom the information will be disclosed.
• Purpose of the disclosure.
• Expiration date (no more than 60 days from authorization date).
• Statements on revocation rights and invalid use beyond the stated purpose, plus a copy to the individual. ([legis.la.gov](https://legis.la.gov/legis/LawPrint.aspx?d=507863))

Separately, to release genetic test results from the medical record (for example, to an out-of-network lab or research collaborator), obtain the patient’s express written consent as required by state law. ([legis.la.gov](https://www.legis.la.gov/legis/Law.aspx?d=965051&utm_source=openai))

Prohibited Genetic Discrimination

Louisiana’s Genetic Discrimination Prohibition in the workplace bars employers from discriminating based on protected genetic information, from requiring or purchasing such information, and from placing genetic data in personnel files. Limited exceptions exist (e.g., narrow post‑offer medical assessments, voluntary genetic monitoring with authorization), and any acquired data must be handled as confidential medical records. Employers must also post required notices. ([legis.la.gov](https://www.legis.la.gov/legis/Law.aspx?d=83889))

These state protections operate alongside federal baseline rules under the Genetic Information Nondiscrimination Act (GINA), which restricts employer handling of genetic information nationwide. ([eeoc.gov](https://www.eeoc.gov/laws/guidance/what-you-should-know-questions-and-answers-about-genetic-information))

Ownership of Genetic Information

Two ownership concepts apply in Louisiana. First, for health insurance contexts, an insured’s or enrollee’s genetic information is the property of that individual; no one may retain it without proper authorization (subject to limited exceptions). ([legis.la.gov](https://legis.la.gov/legis/LawPrint.aspx?d=507863))

Second, as Medical Record Confidentiality law clarifies, the physical medical record (where genetic results reside) is the provider’s business record—but patients have robust rights of access and control over disclosures of their genetic results. Treat record custody (provider) and data rights (patient) as distinct obligations in your policies and consent workflows. ([legis.la.gov](https://www.legis.la.gov/legis/Law.aspx?d=964709))

Genetic Information in Insurance

Health insurance

Health insurers may not request genetic information for underwriting, require genetic testing, or use genetic information to set eligibility or premiums. They must obtain Written Informed Consent to access genetic information from the insured or from a DNA sample, and a general medical release is not enough. There are narrow exceptions for payment determinations and IRB‑compliant research, subject to strict conditions. ([legis.la.gov](https://legis.la.gov/legis/LawPrint.aspx?d=507863))

Life and long‑term care insurance

Louisiana separately restricts life and long‑term care insurers. They cannot require or request a genetic test and cannot penalize people for participating in genetic testing or research; however, they may consider genetic information contained in an applicant’s medical record when it is relevant to mortality or morbidity and grounded in sound actuarial principles. Purchasing genetic information requires the individual’s written consent. ([legis.la.gov](https://www.legis.la.gov/legis/Law.aspx?d=1240064))

PPOs and prenatal testing references

Preferred provider organizations must follow the state’s genetic‑information rules (including prenatal test results) referenced in Title 22. Align your network and payer workflows accordingly. ([legis.la.gov](https://legis.la.gov/legis/Law.aspx?d=98168))

Genetic Testing Leave of Absence

When medically necessary, employees are entitled to one day of leave to obtain genetic testing or preventive cancer screening. Employees must provide at least 15 days’ notice when feasible, make reasonable scheduling efforts, and, if requested, provide documentation that testing occurred; they are not required to disclose results. The leave is unpaid, but employees may substitute accrued paid time off. Employers must post a notice describing these rights. ([legis.la.gov](https://www.legis.la.gov/legis/Law.aspx?d=1336864))

Genetic Information in Employment

In daily HR practice, you may not collect, require, or purchase genetic information; you may not disclose it (with narrow legal exceptions); and you must store any genetic data separately from personnel files as confidential medical records. If you conduct legally permitted genetic monitoring (e.g., toxin exposure programs), you must obtain prior, knowing, voluntary, Written Informed Consent and provide aggregate, non‑identifying results to management. ([legis.la.gov](https://www.legis.la.gov/legis/Law.aspx?d=83889))

Conclusion

For carrier screening panels, build a consent stack that distinguishes general treatment consent from Genetic Data Authorization, default to non‑disclosure without express written consent, and route insurer requests through the state‑mandated authorization framework. Pair strict Medical Record Confidentiality with clear employee and insurance safeguards to maintain compliance across clinical, billing, and HR touchpoints. ([legis.la.gov](https://www.legis.la.gov/legis/Law.aspx?d=965051&utm_source=openai))

FAQs

What are the consent requirements for genetic testing in Louisiana?

Clinically, you obtain informed consent for testing as part of treatment and must secure the patient’s express written consent before disclosing results. For insurers, Louisiana requires Written Informed Consent and a purpose‑specific Genetic Data Authorization; a general medical release is not sufficient. ([legis.la.gov](https://www.legis.la.gov/legis/Law.aspx?d=965051&utm_source=openai))

How is genetic information protected in medical records?

Genetic test results are confidential, form part of the medical record, and may be released only with the individual’s express written consent. Providers own the physical record but must protect confidentiality and provide copies to patients upon request, subject to narrow exceptions. ([legis.la.gov](https://www.legis.la.gov/legis/Law.aspx?d=965051&utm_source=openai))

Can insurers request genetic information without consent?

Health insurers cannot request genetic information for underwriting or require testing, and they may not obtain genetic information from the insured or a DNA sample without Written Informed Consent (limited exceptions apply, such as payment determinations). Life and long‑term care insurers face separate limits and may consider genetic data in existing medical records only under actuarially sound conditions. ([legis.la.gov](https://legis.la.gov/legis/LawPrint.aspx?d=507863))

What limits exist on genetic testing in employment situations?

Employers may not discriminate based on protected genetic information, may not collect or purchase it, and must keep any genetic data as confidential medical records, separate from personnel files. Narrow exceptions (e.g., voluntary genetic monitoring, certain subpoenas) apply, and employers must post required notices. ([legis.la.gov](https://www.legis.la.gov/legis/Law.aspx?d=83889))